299 related articles for article (PubMed ID: 34229470)
1. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.
Zhang W; Torres-Rojas C; Yue J; Zhu BM
Exp Biol Med (Maywood); 2021 Aug; 246(16):1810-1815. PubMed ID: 34229470
[TBL] [Abstract][Full Text] [Related]
2. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.
Nowicka A; Marini FC; Solley TN; Elizondo PB; Zhang Y; Sharp HJ; Broaddus R; Kolonin M; Mok SC; Thompson MS; Woodward WA; Lu K; Salimian B; Nagrath D; Klopp AH
PLoS One; 2013; 8(12):e81859. PubMed ID: 24312594
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.
Muñoz-Galván S; Carnero A
Cells; 2020 Jun; 9(6):. PubMed ID: 32512891
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling.
Qian J; LeSavage BL; Hubka KM; Ma C; Natarajan S; Eggold JT; Xiao Y; Fuh KC; Krishnan V; Enejder A; Heilshorn SC; Dorigo O; Rankin EB
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34396988
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer.
Lin CN; Liang YL; Tsai HF; Wu PY; Huang LY; Lin YH; Kang CY; Yao CL; Shen MR; Hsu KF
J Biomed Sci; 2024 Jun; 31(1):62. PubMed ID: 38862973
[TBL] [Abstract][Full Text] [Related]
6. An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum.
Wong T; Tedja R; Chehade H; Morris R; Alvero AB; Mor G
J Vis Exp; 2024 Jan; (203):. PubMed ID: 38345216
[TBL] [Abstract][Full Text] [Related]
7. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
Motohara T; Masuda K; Morotti M; Zheng Y; El-Sahhar S; Chong KY; Wietek N; Alsaadi A; Carrami EM; Hu Z; Artibani M; Gonzalez LS; Katabuchi H; Saya H; Ahmed AA
Oncogene; 2019 Apr; 38(16):2885-2898. PubMed ID: 30568223
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability.
Xu Q; Lin YB; Li L; Liu J
Biochem Biophys Res Commun; 2020 Jun; 526(4):857-864. PubMed ID: 32278547
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ovarian cancer stem cells or tumor-initiating cells.
Kwon MJ; Shin YK
Int J Mol Sci; 2013 Mar; 14(4):6624-48. PubMed ID: 23528891
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer stem cells and their role in drug resistance.
Pieterse Z; Amaya-Padilla MA; Singomat T; Binju M; Madjid BD; Yu Y; Kaur P
Int J Biochem Cell Biol; 2019 Jan; 106():117-126. PubMed ID: 30508594
[TBL] [Abstract][Full Text] [Related]
11. Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.
Wang X; Li X; Fu X; Bai M; Li X; Mei Q; Nie J; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):270-8. PubMed ID: 25929861
[TBL] [Abstract][Full Text] [Related]
12. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
13. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
[TBL] [Abstract][Full Text] [Related]
14. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
Thibault B; Castells M; Delord JP; Couderc B
Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
[TBL] [Abstract][Full Text] [Related]
17. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
[TBL] [Abstract][Full Text] [Related]
18. Role of mesenchymal cells in the natural history of ovarian cancer: a review.
Touboul C; Vidal F; Pasquier J; Lis R; Rafii A
J Transl Med; 2014 Oct; 12():271. PubMed ID: 25303976
[TBL] [Abstract][Full Text] [Related]
19. Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through taurine generation in ovarian cancer cells.
Bishnu A; Sakpal A; Ghosh N; Choudhury P; Chaudhury K; Ray P
Int J Biochem Cell Biol; 2019 Feb; 107():116-127. PubMed ID: 30593952
[TBL] [Abstract][Full Text] [Related]
20. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]